N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142660 |
| CAS No | NA |
| Mol.F. | C17H14N6O2 |
| Mol.Wt. | 334.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142661 |
| CAS No | NA |
| Mol.F. | C28H20ClF3N8O2 |
| Mol.Wt. | 592.97 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142662 |
| CAS No | NA |
| Mol.F. | C29H23F3N8O2 |
| Mol.Wt. | 572.55 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142663 |
| CAS No | NA |
| Mol.F. | C18H15N5O3 |
| Mol.Wt. | 349.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142664 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O2 |
| Mol.Wt. | 558.53 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142665 |
| CAS No | NA |
| Mol.F. | C20H18F3N7O2 |
| Mol.Wt. | 445.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142666 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O3 |
| Mol.Wt. | 574.52g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142667 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O4 |
| Mol.Wt. | 590.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142668 |
| CAS No | NA |
| Mol.F. | C19H19N5O2 |
| Mol.Wt. | 349.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142669 |
| CAS No | NA |
| Mol.F. | C37H27F3N12O2 |
| Mol.Wt. | 728.70 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142670 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O3 |
| Mol.Wt. | 574.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142671 |
| CAS No | NA |
| Mol.F. | C19H14F3IN4O2 |
| Mol.Wt. | 514.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142672 |
| CAS No | NA |
| Mol.F. | C21H21N5O3 |
| Mol.Wt. | 391.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142673 |
| CAS No | NA |
| Mol.F. | C15H11N3O3 |
| Mol.Wt. | 281.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142674 |
| CAS No | NA |
| Mol.F. | C15H14ClN3O2 |
| Mol.Wt. | 303.75 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142675 |
| CAS No | NA |
| Mol.F. | C12H8ClN3O3 |
| Mol.Wt. | 277.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |